patent.fyi
Applications  /  US 2026/0355258
United States Patent Application Publication

US 2026/0355258 A1

Published
Nov 12, 2026
Filed
Jun 16, 2025
Earliest date on the face
May 12, 2025
Classification
A61K 35/586
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Vaginal estradiol insert

What ifWhat if the medication uses estradiol to reduce pain during sex associated with menopausal vaginal dryness?
Claim language“Testudinis Carapax et Plastrum”

A dissolving vaginal insert releases estradiol at the vaginal mucosa. Estradiol promotes maturation of the vaginal epithelium and improves lubrication.

1.1Pelvic floor biofeedback

What ifWhat if pelvic floor biofeedback addresses pain during penetration associated with excessive pelvic floor muscle activity?
Claim language“in preparing medications”

Surface electromyography electrodes measure pelvic floor muscle activity and display the signal as a moving trace. The patient uses the trace during guided breathing and relaxation exercises to practice lowering resting muscle activity.

1.1Graduated vaginal dilator training

What ifWhat if graduated vaginal dilators address penetration difficulty associated with involuntary pelvic floor tightening?
Claim language“in preparing medications”

A set of smooth dilators provides progressively larger diameters. The patient practices comfortable insertion with the smallest size while relaxing the pelvic floor and advances when insertion at the current size is comfortable.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Oral dosing in a research setting

An oral preparation containing milled turtle carapace and plastron is dispensed in a supervised clinical research setting for female sexual dysfunction. A pharmacy packages the preparation and a matching placebo in coded unit-dose containers. Study staff record each administration and collect participant-reported outcomes at scheduled visits.

Component substitution

Rice starch as a capsule filler

Pregelatinized rice starch replaces lactose as the filler in an oral capsule containing milled turtle carapace and plastron. The shell powder is blended with the starch by geometric dilution before the blend enters the capsule filler. Capsule fill weight and blend uniformity are checked before packaging.

Parameter or scale variation

Pilot batches at two fill counts

An oral capsule line makes pilot batches of 100 and 1,000 capsules from the same proportions of milled turtle carapace and plastron and excipients. The target fill weight per capsule stays constant, and the larger batch is split into ten 100-capsule filling runs. Samples from the beginning, middle, and end of each run are weighed to compare fill consistency.

Combination with existing systems

Capsule dispensing through an electronic cabinet

Individually packaged oral capsules containing milled turtle carapace and plastron are stocked in a dedicated compartment in an electronic medication dispensing cabinet. Each package carries a barcode linked to its lot and expiration date. The cabinet records package withdrawals against a dispensing order, and a bedside scanner matches the package to the patient record.

Automated or data-driven variant

Automatic inspection of capsule fill weight

An in-line checkweigher measures each filled oral capsule containing milled turtle carapace and plastron. A controller compares each gross weight with upper and lower limits set for the capsule size and target fill weight. A timed air jet diverts out-of-range capsules, and the controller records each measurement and rejection against the batch identifier.

Sensor logging for capsule storage

Sealed packs of oral capsules containing milled turtle carapace and plastron are stored in a cabinet fitted with temperature and relative humidity sensors. A logger records both measurements at five-minute intervals and associates the readings with the lots stored in the cabinet. Software flags lots that are present when a reading crosses a configured storage limit.

Specific version of a part

Milled shell powder capsule

Dried carapace and plastron are milled and passed through a sieve to control particle size. The sifted powder is blended with microcrystalline cellulose and filled into hard capsules.

Aqueous extract oral liquid

A hot water extract of carapace and plastron is filtered and concentrated under reduced pressure. Purified water and glycerol bring the concentrate to a specified solids content before it is filled into single dose containers.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2016/0361367 A1
Published
Dec 15, 2016
Filed
Jun 10, 2016
Class
A61K 35/586
Document BUS 2024/0131106 A1
Published
Apr 25, 2024
Filed
Oct 18, 2022
Class
A61K 36/725
Claim 1
Document A
Document B
1.1An application of Testudinis Carapax et Plastrum in preparing medications for treating female sexual dysfunction.
A pharmacopuncture composition for eye health according to the present invention includes total nine kinds of medicinal materials such as Cornic fructus, Ligustri fructus, Acori rhizome, Euphoria longana, Testudinis carapax, Lycii fructus, Rehmanniae radix, Asparagi tuber, and Cnidii rhizoma.
A · US 2016/0361367 A1 · ¶ 25
A preparation method of a honeyed pill for treating pulmonary nodules followed the following steps: Step 1, 30 g of Ziziphi Spinosae Semen, 30 g of Rehmaniae Radix, 30 g of Trichosanthis Radix, 30 g of Coicis Semen Preparata, 50 g of Paeoniae Radix Alba, 20 g of Ginseng Radix et Rhizoma, 10 g of Olibanum, 10 g of Myrrha, 30 g of Agrimoniae Herba, 30 g of Testudinis Carapax et Plastrum Preparata Cum Aceto, 30 g of Trionycis Carapax Preparata Cum Aceto, 20 g of Alpiniae Oxyphyl
B · US 2024/0131106 A1 · ¶ 87

An empty cell means only that no passage was reproduced there.

Statements in these documents
In conformity with such need in eye health, oriental medicinal materials for eye health have been proposed even by the field of oriental medicine, but up to now, the oriental medicinal materials beneficial to eye health on the basis of herbology are simply mixed and eaten just as herbal medicinal preparations.
A · US 2016/0361367 A1 · ¶ 5
Accordingly, the present invention has been made in view of the above-mentioned problems occurring in the prior art, and it is an object of the present invention to provide a pharmacopuncture composition for eye health that includes medicinal materials beneficial to the improvement of eye health and a method for manufacturing the same that is conducted according to the characteristics of the medicinal materials.
A · US 2016/0361367 A1 · ¶ 7
Therefore, early intervention treatment is particularly important and has positive significance for the prognoses of patients.
B · US 2024/0131106 A1 · ¶ 2
Discussions on the etiology, pathogenesis, therapeutic principle, and effective prescriptions of pulmonary nodules in TCM are almost blank in the field of TCM.
B · US 2024/0131106 A1 · ¶ 2
Cite aspatent.fyi, US 2026/0355258 A1, claim 1, first published 2026-11-19T09:44:02-05:00, https://patent.fyi/US20260355258/, SHA-256 9f266d5703239676279060a2b4db991e0bd19c890b352906526ae580f09e04d4
First published
Permanent addresshttps://patent.fyi/US20260355258/
Content fingerprint (SHA-256)9f266d5703239676279060a2b4db991e0bd19c890b352906526ae580f09e04d4
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi